Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial

G. Fätkenheuer, C. Duvivier, A. Rieger, J. Durant, D. Rey, W. Schmidt, A. Hill, Y. van Delft, S. Marks, N. Vetter, R. Greil, C. Pedersen, M. Storgaard, P. Morlat, C. Katlama, L. Cotte, C. Duvvier, S. Esser, C. Stellbrink, M. StollC. Stephan, A. Stoehr, J. Rockstroh, D. Banhegyi, L. Itzchak, E. Shahar, S. Maayan, D. Turner, A. Lazzarin, A. Antinori, G. Carosi, L. Minoli, G. di Perri, G. Filice, M. Andreoni, D. Duiculescu, S. Rugina, S. Erscoiu, A. Streinu, A. Pronin, V. Pokrovsky, B. Gruzdev, A. Yakovlev, E. Voronin, B. Clotet, J. Gatell, J. Arribas, D. Podzamczer, P. Domingo, C. Miralles Alvarez, J. Hernandez Quero, H. Furrer, J. Feher, M. Johnson, J. Fox, M. Nelson, M. Fisher, C. Orkin

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial'. Together they form a unique fingerprint.

Medicine & Life Sciences